Related Experiment Videos
Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan
Han-Meng Wu1, Kin-Sun Wong, Yhu-Chering Huang
1Division of Pediatric Pulmonology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, 33305, Taiwan.
Abstract:
The aim of this study was to estimate the prevalence of macrolide-resistant Mycoplasma pneumoniae in Taiwan and to compare the clinical courses of pediatric patients with macrolide-resistant (MR) M. pneumoniae and macrolide-susceptible (MS) M. pneumoniae infection. Patients were among the children admitted to Chang Gung Children's Hospital with mycoplasmal pneumonia between February and December 2011. Detection for macrolide resistance was performed after informed consent was obtained. We retrospectively reviewed medical records and compared the clinical courses of two groups of patients of 73 children enrolled into our study. The rate of macrolide resistance in M. pneumoniae was 12.3 %. Longer hospital stay was observed in the MR patients than MS patients [median, 7 days vs. 5 days (P = 0.019)]. Clinical features or radiographic or laboratory findings are not helpful to differentiate MR from MS mycoplasmal pneumonia. Early diagnosis of MR mycoplasmal pneumonia is crucial for the best management of these patients and obviates the need for extensive etiological searches of these nonresponding cases.
Insights
Macrolide-resistant Mycoplasma pneumoniae affects 12.3% of pediatric pneumonia cases in Taiwan. Resistant infections lead to longer hospital stays, highlighting the need for early diagnosis and appropriate treatment strategies.
Area of Science:
- Pediatrics
- Infectious Diseases
- Microbiology
Background:
- Mycoplasma pneumoniae is a common cause of community-acquired pneumonia in children.
- Macrolide resistance in M. pneumoniae is a growing global concern, potentially impacting treatment efficacy.
- Understanding local resistance patterns is crucial for effective clinical management.
Purpose of the Study:
- To determine the prevalence of macrolide-resistant (MR) M. pneumoniae in pediatric patients in Taiwan.
- To compare the clinical outcomes of children with MR M. pneumoniae versus macrolide-susceptible (MS) M. pneumoniae infections.
- To identify clinical predictors for differentiating MR from MS M. pneumoniae pneumonia.
Main Methods:
- Retrospective review of medical records of pediatric patients diagnosed with mycoplasmal pneumonia.
- Macrolide resistance detection for M. pneumoniae isolates.
- Comparison of clinical courses, including hospital stay duration, between MR and MS M. pneumoniae groups.
Main Results:
- The prevalence of macrolide resistance in M. pneumoniae was 12.3% among the studied pediatric population.
- Patients with MR M. pneumoniae experienced significantly longer hospital stays (median 7 days) compared to those with MS M. pneumoniae (median 5 days; P=0.019).
- Clinical, radiographic, and laboratory findings did not reliably differentiate between MR and MS M. pneumoniae pneumonia.
Conclusions:
- Macrolide resistance in pediatric M. pneumoniae infections is a significant issue in Taiwan.
- Early diagnosis of macrolide-resistant M. pneumoniae is essential for optimal patient management and to avoid unnecessary investigations.
- Effective treatment strategies for macrolide-resistant M. pneumoniae require further investigation and development.
Related Concept Videos
Atypical Pneumonia
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance